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Much has recently been discovered with respect to genomic and transcriptomic alterations 
underlying medulloblastoma, the most common embryonal brain tumor. One of the most 
important insights is that medulloblastoma is not a single disease, but rather comprises four 
core molecular subgroups. We therefore sought to characterize global epigenetic alterations 
occurring in these medulloblastoma subgroups as part of the International Cancer Genome 
Project (ICGC) PedBrain Tumor project. In order to get a global, base-resolution profile of 
the medulloblastoma methylome, we performed high-coverage whole-genome bisulfite 
sequencing on 34 primary tumors and 8 normal cerebellum samples. To supplement this, we 
conducted genome-wide methylome analysis on >300 primary medulloblastomas (frozen and 
FFPE) using the Illumina Infinium HumanMethylation450 bead array. Matched transcriptome 
data from either microarrays or RNA sequencing, as well as miRNA sequencing data, was 
available for over 100 tumors, allowing us to correlate methylation with gene expression. 
DNA methylation was found to be correlated with overall expression levels and alternative 
isoforms in numerous regions. Interestingly, the strongest association was not at classical 
CpG islands, but downstream of transcription start sites. Differential methylation/expression 
between subgroups was observed for many known subgroup markers, but also novel 
candidiate genes (e.g. ARID1B, LIN28B) and miRNAs. Large-scale partially methylated 
domains (PMDs), identified in WNT and Group 3 tumors, were correlated with low gene 
expression and an increased somatic mutation rate. This study provides an extremely detailed 
view of the methylomic landscape of medulloblastoma, revealing novel insights into the 
epigenetic regulation of subgroup-specific mRNA and miRNA expression. Furthermore, the 
scope of the study has allowed us to identify associations between DNA methylation, gene 
expression, and alternative splicing / promoter usage which have wider implications for basic 
biology. These data will provide a basis both for future research studies and for the 
development of enhanced therapeutic modalities. 
 
